Countable Labs
Develops single-molecule PCR technology for genomics measurement
$26MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops single-molecule PCR technology for genomics measurement
Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies